Buy Now

Have you purchased yours? Buy Your All-Access Pass now & get lifetime access to all replays and slides! (Lock in the lowest price today)

Microbiota Transplant for Autism

A talk by James Adams PhD

Register to watch this content

By submitting your email you agree to the terms
Watch this content now

Tracks covered by this talk

About this talk

We conducted a Phase 1 clinical trial of an Investigational New Drug involving 2 weeks of oral vancomycin (to kill unhealthy gut bacteria), followed by a bowel cleanse and then Full Spectrum Microbiota (FSM) from healthy donors to create a healthy GI microbiome. We treated children ages 7-17 years who had ASD and moderate or severe gastrointestinal problems. We administered MTT in two stages: an oral or rectal dose, followed by 7-8 weeks of oral administration. There was an 82% reduction in GI symptoms, and a 25% reduction in autism symptoms. Their bacterial diversity significantly increased, from 25% below normal to normal. At the 8-week follow-up, the improvements in GI symptoms, ASD symptoms, and microbiome diversity were stable. At the two-year follow-up, most of the GI improvements remained, and there was a 47% reduction in ASD symptoms compared to baseline.

Have you got yours yet?

Our All-Access Passes are a must if you want to get the most out of this event.

Check them out

Proudly supported by

Want to sponsor? Contact us to find out more.